NCT02439047 2026-03-16
MESO-PATCH
Centre Oscar Lambret
Phase NA Terminated
Clinical Trials
170 trialsNCT05477784 2026-01-21
EC-PC
University of Washington
Phase NA Terminated
NCT04824859 2026-01-05
eGAP
University of Rochester
Phase NA Terminated
NCT06162351 2026-01-02
TOPOLOGY
Institut Curie
Phase 2 Terminated
NCT06337630 2026-01-02
POP-ART
Institut Curie
Phase 1 Terminated
NCT05746169 2025-12-30
Discovering Cancer Risks From Environmental Contaminants and Maternal/Child Health
University of California, San Francisco
Terminated
NCT03971266 2025-09-02
Movement and Fitness Trackers in Determining Performance Status
University of Southern California
Phase NA Terminated
NCT03057639 2025-07-25
Clinical Model in Evaluating Clinical, Psychosocial, and Health Economic Factors in Adolescent and Young Adult Patients With Cancer
University of Southern California
Terminated
NCT02420509 2025-06-04
Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
University of California, San Diego
Terminated
NCT05471271 2025-05-31
IL-2 PET Imaging in Advanced Solid Tumours
University Medical Center Groningen
Phase NA Terminated
NCT01369641 2025-05-16
The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy
Thomas Jefferson University
Phase NA Terminated
NCT01871441 2025-05-16
Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Thomas Jefferson University
Phase 2 Terminated
NCT02170350 2025-04-29
Brief Mindful Meditation Practice in Improving Quality of Life in Patients With Cancer Undergoing Radiation Therapy
Thomas Jefferson University
Phase NA Terminated
NCT01529593 2025-03-24
Temsirolimus in Combination With Metformin in Patients With Advanced Cancers
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT03752203 2025-03-06
Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors
University of Colorado, Denver
Phase NA Terminated
NCT03839940 2025-01-29
MIST
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT03599661 2025-01-09
Developing and Validating Fertilit-e
Wake Forest University Health Sciences
Terminated
NCT05244915 2025-01-06
A Supportive Care Intervention for Older Caregivers of Older Adults with Advanced Cancer
University of Rochester
Phase NA Terminated
NCT04376502 2025-01-03
Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma.
Baptist Health South Florida
Phase NA Terminated
NCT05062447 2024-12-10
EMOCA
Amsterdam UMC, location VUmc
Terminated
NCT03979794 2024-11-14
A Distress Screening and Intervention in Cancer Surgery
Baylor College of Medicine
Phase NA Terminated
NCT05601830 2024-11-06
Natural Killer(NK) Cell Therapy for AML Minimal Residual Disease
Institute of Hematology & Blood Diseases Hospital, China
Phase 1 Terminated
NCT04685798 2024-09-19
Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT
Washington University School of Medicine
Phase NA Terminated
NCT04768153 2024-08-21
RESILIENCE
University Hospital Center of Martinique
Terminated
NCT04534283 2024-08-07
A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.
Indiana University
Phase 2 Terminated
NCT06160700 2024-06-10
Serial Testing To Assess Cognitive Function In Cancer
Indiana University
Terminated
NCT00657098 2024-05-03
Mabtornib
University Medical Center Groningen
Terminated
NCT04738292 2024-05-03
Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)
University of Wisconsin, Madison
Phase 2 Terminated
NCT03396471 2024-04-18
Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary
Hoosier Cancer Research Network
Phase 2 Terminated
NCT01243333 2024-04-17
Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors
University of Utah
Phase NA Terminated
NCT03885908 2024-03-25
Automated Geriatric Co-Management Program in Older Patients With Solid Mass or Nodule Suspicious for Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Terminated
NCT00250055 2024-03-12
Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue
University of New Mexico
Phase NA Terminated
NCT02551458 2024-03-07
Esostrate
Centre Hospitalier Universitaire Dijon
Phase 2/3 Terminated
NCT03997448 2024-02-20
Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149
Big Ten Cancer Research Consortium
Phase 2 Terminated
NCT00277004 2024-02-07
Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer.
University of New Mexico
Terminated
NCT06004141 2024-02-02
LAGUNA
Massachusetts General Hospital
Phase NA Terminated
NCT03300310 2024-02-01
IPIO-PA
Nantes University Hospital
Phase NA Terminated
NCT03874065 2024-01-19
Medical Data Collection in the Formation of Precision Oncology Registry
Wake Forest University Health Sciences
Terminated
NCT00250809 2024-01-12
Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study
University of New Mexico
Phase NA Terminated
NCT00322725 2024-01-11
Bevacizumab (Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review
University of New Mexico
Terminated
NCT03866707 2023-12-20
Epigenetic and Metabolomic Changes in Childhood Cancer Survivors
Wake Forest University Health Sciences
Terminated
NCT04015895 2023-11-02
iDEFCO
Centre Hospitalier Universitaire de Saint Etienne
Terminated
NCT04095091 2023-10-31
Real-time Tumor Localization and Guidance for Radiotherapy Using Ultrasound (US) and Magnetic Resonance (MR)
University of Wisconsin, Madison
Terminated
NCT03722108 2023-10-16
REGIRI
UNICANCER
Phase 1/2 Terminated
NCT01755650 2023-09-13
Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies
Peter MacCallum Cancer Centre, Australia
Phase EARLY_PHASE1 Terminated
NCT04278534 2023-08-30
Virtual Reality for the Education of Cancer Patients Undergoing Radiation Therapy
OHSU Knight Cancer Institute
Phase NA Terminated
NCT02860481 2023-08-24
FRACTal
Institut Curie
Phase NA Terminated
NCT04729725 2023-08-14
SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT02478320 2023-07-17
Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT03995927 2023-06-29
PROCC
Wake Forest University Health Sciences
Terminated